Zyversa Therapeutics Inc (ZVSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZVSA | AMGN | VRTX | BMY | GILD |
| Company | Zyversa Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 1.2500 | 319.59 | 503.00 | 59.82 | 96.35 |
| High | 1.3500 | 321.22 | 508.04 | 60.62 | 96.84 |
| Low | 1.2000 | 293.80 | 489.02 | 58.81 | 94.22 |
| Last | 1.2600 | 298.84 | 490.00 | 59.02 | 94.35 |
| Change | -0.0400 | -22.97 | -11.72 | -0.80 | -2.68 |
| % Change | -3.08% | -7.14% | -2.34% | -1.34% | -2.76% |
| Volume | 264,400 | 6,680,200 | 1,364,500 | 15,141,199 | 9,322,600 |
| 20-Day Average Volume | 3,648,830 | 2,132,475 | 1,151,710 | 10,482,615 | 6,381,685 |
| Previous Close | 1.3000 | 321.81 | 501.72 | 59.82 | 97.03 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9536 | 318.13 | 484.39 | 54.24 | 90.07 |
| 20-Day Raw Stochastic | 2.76% | 14.63% | 47.33% | 77.78% | 65.79% |
| 20-Day Relative Strength | 32.83% | 34.02% | 53.21% | 66.38% | 66.87% |
| Weighted Alpha | -92.27 | +6.61 | +34.01 | +26.62 | +35.61 |
| Today's Opinion | 100% Sell | 40% Sell | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 88% Sell | 56% Buy | 48% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -50.39% since 11/05/24 | -6.40% since 11/05/24 | -1.98% since 11/05/24 | +5.49% since 11/05/24 | +4.58% since 11/05/24 |
| Low | 1.2000 on 11/12/24 | 293.80 on 11/12/24 | 485.29 on 11/06/24 | 53.97 on 11/08/24 | 90.50 on 11/06/24 |
| High | 1.8900 on 11/07/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 1-Month | |||||
| %Chg | -45.69% since 10/11/24 | -8.99% since 10/11/24 | +1.72% since 10/11/24 | +13.07% since 10/11/24 | +11.07% since 10/11/24 |
| Low | 1.2000 on 11/12/24 | 293.80 on 11/12/24 | 463.14 on 11/01/24 | 51.31 on 10/15/24 | 84.34 on 10/14/24 |
| High | 3.3700 on 11/05/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -55.79% since 08/12/24 | -6.61% since 08/12/24 | +5.49% since 08/12/24 | +25.41% since 08/12/24 | +29.26% since 08/12/24 |
| Low | 1.2000 on 11/12/24 | 293.80 on 11/12/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 72.67 on 08/13/24 |
| High | 3.9600 on 08/22/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -76.54% since 05/10/24 | -3.65% since 05/10/24 | +15.90% since 05/10/24 | +31.33% since 05/10/24 | +43.04% since 05/10/24 |
| Low | 1.2000 on 11/12/24 | 293.80 on 11/12/24 | 422.44 on 05/14/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 6.3000 on 07/10/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,297 | 160,636,368 | 126,189,208 | 119,703,008 | 117,464,992 |
| Shares Outstanding, K | 1,029 | 537,533 | 257,529 | 2,028,177 | 1,244,992 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -98,300,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -2,760,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.65 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -3.31 on 08/09/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/12/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.74 | 0.00 | 51.13 | 21.90 |